[1]鲁 霞,曹党恩,李晓兰.多囊卵巢综合征患者血清GnSAF, Irisin, Copeptin 表达水平及其与妊娠结局的相关性研究[J].现代检验医学杂志,2022,37(06):34-39+87.[doi:10.3969/j.issn.1671-7414.2022.06.007]
　LU Xia,CAO Dang-en,LI Xiao-lan.Changes of Serum GnSAF, Irisin and Copeptin Levels in Patients with Polycystic Ovary Syndrome and Their Relationship with Pregnancy Outcomes[J].Journal of Modern Laboratory Medicine,2022,37(06):34-39+87.[doi:10.3969/j.issn.1671-7414.2022.06.007]
点击复制

多囊卵巢综合征患者血清GnSAF, Irisin, Copeptin 表达水平及其与妊娠结局的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年06期
页码:
34-39+87
栏目:
论著
出版日期:
2022-11-15

文章信息/Info

Title:
Changes of Serum GnSAF, Irisin and Copeptin Levels in Patients with Polycystic Ovary Syndrome and Their Relationship with Pregnancy Outcomes
文章编号:
1671-7414(2022)06-034-07
作者:
鲁 霞1; 曹党恩1; 李晓兰2
(1. 湖北省大冶市人民医院妇产科，湖北大冶435199；2. 宜昌市第二人民医院，三峡大学第二人民医院妇产科，湖北宜昌 443008)
Author(s):
LU Xia1; CAO Dang-en1; LI Xiao-lan2
(1.Department of Obstetrics and Gynecology, the People’s Hospital of Daye City, Hubei Daye 435199, China； 2.Department of Obstetrics and Gynecology, the Second People’s Hospital of Yichang City, the Second People’s Hospital of Three Gorges University, Hubei Yichang 443008, China)
关键词:
多囊卵巢综合征; 促性腺激素峰抑制因子; 鸢尾素; 和肽素
分类号:
R711.75；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.06.007
文献标志码:
A
摘要:
目的 探讨多囊卵巢综合征(polycystic ovary syndrome，PCOS)患者血清促性腺激素峰抑制因子(gonadotropinpeak suppressor factor，GnSAF)、鸢尾素(Irisin)、和肽素(Copeptin)表达水平及其与妊娠结局的关系。方法 将2018 年10 月～ 2020 年10 月湖北省大冶市人民医院诊治的PCOS 患者106 例设为PCOS 组，另选择同期82 例健康体检女性为对照组。收集两组有关临床资料，检测比较两组血清GnSAF, Irisin 和Copeptin 水平，分析PCOS 患者血清GnSAF , Irisin , Copeptin 水平与临床指标的相关性，应用Logistic 回归分析探讨PCOS 发生的影响因素，并对PCOS 组行常规西医药物治疗，对比不同妊娠结局患者血清GnSAF，Irisin 和Copeptin 水平，应用受试者工作特征(ROC)曲线观察血清GnSAF，Irisin 和Copeptin 对患者妊娠结局的预测价值。结果 PCOS 组体质量指数(body mass index，BMI)25.28±3.76kg/m2、空腹血糖(fasting blood glucose，FPG) 5.47±0.58mmol/L， 空腹胰岛素(fasting insulin，FINS)15.61±2.75mIU/L，稳态模型胰岛素抵抗指数(homeostasis model insulin resistance index，HOMA-IR)3.79±0.83，三酰甘油(triglyceride，TG)1.87±0.58mmol/L，睾酮(testosterone，T)1.94±0.53nmol/L，促黄体生成素(luteinizinghormone，LH)12.86±2.28mU/ml 及血清GnSAF(22.00±1.93pg/ml), Irisin(3.09±0.69ng/L) ,Copeptin(12.61±3.27pmol/L) 水平均高于对照组(22.06±3.27kg/m2，5.14±0.43mmol/L ，9.04±2.49mIU/L，2.07±0.64，1.42±0.49mmol/L，1.21±0.34nmol/L，5.63±1.07mU/ml,19.82±2.26pg/ml，2.07±0.63ng/L ，8.62±1.94pmol/L)； 高密度脂蛋白胆固醇(high-density lipoprotein cholesterol，HDL-C)1.24±0.21mmol/L，雌二醇(estradiol，E2) 112.48±19.55pmol/L 水平均低于对照组(1.40±0.24mmol/L，134.06±24.16pmol/L)，差异具有统计学意义(t ＝ 4.315 ～ 26.532，均P ＝ 0.000)。Pearson 相关系数模型分析显示，血清GnSAF 水平与E2 呈负相关(r ＝ -0.308)，血清Irisin, Copeptin 水平与BMI ，FPG, FINS, HOMA-IR, TG 水平呈正相关(r ＝ 0.321 ～ 0.649)，与HDL-C 水平呈负相关(r ＝ -0.409)，且血清Irisin水平与T 水平呈正相关(r ＝ 0.321)，差异均有统计学意义(均P ＜ 0.05)。Logistic 回归分析发现，血清GnSAF,Irisin 和Copeptin 均为PCOS 发病的独立危险因素(Waldχ2 ＝ 10.246 ～ 15.464, OR ＝ 2.482 ～ 3.438, 均P ＜ 0.05)。妊娠成功PCOS 患者血清GnSAF(21.13±1.85pg/ml ), Irisin(2.77±0.64ng/L)和Copeptin(11.02±3.04pmol/L)水平均低于妊娠失败患者(22.24±2.04pg/ml ，3.18±0.72ng/L ，13.05±3.48pmol/L)，差异具有统计学意义(t ＝ 2.354，20472，2.540, 均P ＜ 0.05)。绘制ROC 曲线预测模型可知，血清GnSAF, Irisin 和Copeptin 三项指标均对患者妊娠失败有一定预测价值，采取联合时曲线下面积(AUC)最大，为0.948，敏感度和特异度分别为91.57% 和86.96%。结论 PCOS 患者血清GnSAF, Irisin 和Copeptin 水平呈异常高表达，且表达与临床指标有关，可为预后预测提供参考。
Abstract:
Objective To investigate the expression levels of serum gonadotropin peak suppressor factor (GnSAF), Irisin and Copeptinin patients with polycystic ovary syndrome (PCOS) and their relationship with pregnancy outcomes. Methods A total of 106 PCOS patients diagnosed and treated in the People’s Hospital of Daye City, Hubei Province from October 2018 to October 2020 were selected as the PCOS group, and 82 healthy women who underwent physical examination during the same period were selected as the control group. The relevant clinical data of the two groups were collected, and the serum levels of GnSAF, Irisin and Copeptin were detected and compared between the two groups.The correlation between serum GnSAF, Irisin and Copeptin levels and clinical indicators in PCOS patients was analyzed, and the influencing factors of PCOS were analyzed by logistic regression analysis. The PCOS group was treated with conventional western medicine, the serum levels of GnSAF, Irisin and Copeptin were compared in patients with different pregnancy outcomes, and the receiver operating characteristic (ROC) curve was used to observe the predictive value of serum GnSAF, Irisin and Copeptin on the pregnancy outcome of patients. Results PCOS group body mass index(BMI，25.28±3.76kg/m2), fasting blood glucose (FPG， 5.47±0.58mmol/L), fasting insulin (FINS，15.61±2.75mIU/L), homeostasis model insulin resistance index (HOMA-IR，3.79±0.83), triglyceride (TG ， 1.87±0.58mmol/L), testosterone(T，1.94±0.53nmol/L), luteinizing hormone (LH，12.86±2.28mU/ml) and serum GnSAF(22.00±1.93pg/ml ), Irisin(3.09±0.69ng/L), Copeptin(12.61±3.27pmol/L) levels were higher than those in the control group(22.06±3.27kg/m2，5.14±0.43mmol/L，9.04±2.49mIU/L，2.07±0.64，1.42±0.49mmol/L，1.21±0.34nmol/ L，5.63±1.07mU/ml, 19.82±2.26pg/ml，2.07±0.63ng/L，8.62±1.94pmol/L), the levels of high-density lipoprotein cholesterol (HDL-C，1.24±0.21mmol/L )and estradiol (E2，112.48±19.55pmol/L ) levels were lower than those of the control group(1.40±0.24mmol/L，134.06±24.16pmol/L), and the differences were statistically significan(t t＝4.315～26.532， all P ＝ 0.000). Pearson correlation coefficient model analysis showed that serum GnSAF levels were negatively correlated with E2(r ＝ -0.308). Serum Irisin, Copeptin levels were positively correlated with BMI, FPG, FINS, HOMA-IR, TG levels(r ＝ 0.321 ～ 0.649), and negative correlation with HDL-C levels(r ＝ -0.409). Serum Irisin level was positively correlated with T level(r ＝ 0.321)，the differences were statistically significant (all P ＜ 0.05).Logistic regression analysis found that serum GnSAF, Irisin and Copeptin were independent risk factors for PCOS (Waldχ2 ＝ 10.246 ～ 15.464,OR ＝ 2.482 ～ 3.438,all P ＜ 0.05).The serum levels of GnSAF(21.13±1.85pg/ml), Irisin(2.77±0.64ng/L) and Copeptin(11.02±3.04pmol/L) in PCOS patients with successful pregnancy were lower than those in patients with pregnancy failure(22.24±2.04pg/ml， 3.18±0.72ng/L ，13.05±3.48pmol/L),the differences were statistically significant (t=2.354, 2.472, 2.540, all P ＜ 0.05). According to the prediction model of ROC curve, the three indexes of serum GnSAF, Irisin and Copeptin had a certain predictive value for pregnancy failure. When combined, the area under the curve(AUC)was the largest(0.948), with a sensitivity of 91.57% and a specificity of 86.96%，respectively .Conclusion The serum levels of GnSAF, Irisin and Copeptinin PCOS patients are abnormally high, and the expressions are related to clinical indicators, which can provide a reference for prognosis prediction.

参考文献/References:

[1] BELENKAIA L V, LAZAREVA L M, WALKER W, et al. Criteria, phenotypes and prevalence of polycystic ovary syndrome[J]. Minerva Ginecologica, 2019, 71(3): 211-223.
[2] 杨滢 , 尹家瑶 , 张小雪．多囊卵巢综合征患者血清和肽素水平与糖脂代谢及 IR的关系研究 [J]．解放军医药杂志 , 2021, 33(1):81-84, 89. YANG Ying, YIN Jiayao, ZHANG Xiaoxue. Relationship of serum Copeptin level with glucose and lipid metabolism and IR in patients with polycystic ovary syndrome [J]. Medical & Pharmaceutical Journal of Chinese People’s Liberation Army, 2021,33(1):81-84,89.
[3] GANIE M A, VASUDEVAN V, WANI I A, et al. Epidemiology, pathogenesis, genetics &management of polycystic ovary syndrome in India[J]. Indian Journal of Medical Research, 2019, 150(4): 333-344.
[4] 杜静 , 李嘉丽 , 晏耀明 , 等 .多囊卵巢综合征患者血清 AMH,LH和 FSH水平检测及临床应用研究 [J].现代检验医学杂志 , 2019, 34(5): 68-71. DU Jing, LI Jiali, YAN Yaoming, et al. Detection and clinical application of serum AMH, FSH and LH in patients with polycystic ovarian syndrome [J]. Journal of Modern Laboratory Medicine, 2019, 34(5): 68-71.
[5] BEHBOUDI-GANDEVANI S, HEDAYATI M, MANSOURNIA M A, et al. The associations between serum concentrations of Irisin and glucose-dependent insulinotropic polypeptide with body mass index among women with and without polycystic ovary syndrome[J]. International Journal of Endocrinology and Metabolism, 2021, 19(4): e111914.
[6] FR?SSING S, NYLANDER M, KISTORP C, et al. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and Copeptinin PCOS[J]. Endocrine Connections, 2018, 7(1): 115-123.
[7] 中华医学会妇产科学分会内分泌学组及指南专家组 .多囊卵巢综合征中国诊疗指南 [J].中华妇产科杂志 , 2018, 53(1):2-6. Endocrinology Subgroup and Expert Panel, Chinese Society of Obstetrics and Gyneocology, Chinese Medical Association. Chinese guideline for diagnosis and management of polycystic ovary syndrome [J]. Chinese Journal of Obstetrics and Gynecology, 2018,53(1):2-6.
[8] ROSENFIELD R L. Current concepts of polycystic ovary syndrome pathogenesis[J]. Current Opinion in Pediatrics, 2020, 32(5): 698-706.
[9] 张萍 , 王坤． GnSAF, LEP和 APN在多囊卵巢综合征患者血清中的表达及其意义 [J].医学临床研究 , 2021, 38(9):1338-1341. ZHANG Ping, WANG Kun. Expression levels and significance of GnSAF, LEP and APN in peripheral blood of polycystic ovarian syndrome [J]. Journal of Clinical Research,2021,38(9):1338-1341.
[10] 田阳 , 谢铁男 , 扈聪 , 等 .不同卵巢储备功能患者血清 GnSAF 水平比较 [J].山东医药 , 2016, 56(35): 73-75. TIAN Yang, XIE Tienan, HU Cong, et al. Comparison of serum GnSAF levels in patients with different ovarian reserve[J]. Shandong Medical Journal, 2016,56(35):73-75.
[11] CHANG C L, HUANG S Y, HSU Y C, et al. The serum level of Irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients[J]. Scientific Reports, 2019, 9(1): 6447.
[12] OLIVEIRA F R, MAMEDE M, BIZZI M F, et al. Effects of short term metformin treatment on brown adipose tissue activity and plasma Irisin levels in women with polycystic ovary syndrome: A randomized controlled trial[J]. Hormone and Metabolic Research, 2020, 52(10): 718-723.
[13] 夏燕 , 孔梅． PCOS患者血清瘦素、鸢尾素、胰岛功能及生殖激素的变化与 BMI变化的关系 [J].解放军预防医学杂志 , 2020, 38(4): 60-62. XIA Yan, KONG Mei. The relationship between changes in serum Leptin, Irisin, pancreatic islet function and reproductive hormones and changes in BMI in patients with PCOS [J]. Journal of Preventive Medicine of Chinese People’s Liberation Army, 2020, 38(4): 60-62.
[14] 张洁 , 万利静 , 王亚芹 , 等 .脂代谢、血清 INH-B, Irisin及 visfatin水平与 PCOS的关系分析 [J].实验与检验医学 , 2020, 38(6):1183-1186. ZHANG Jie, WAN Lijing, WANG Yaqin, et al. Analysis of the relationship between lipid metabolism, serum INH-B, Irisin and visfatin levels and PCOS [J]. Experimental and Laboratory Medicine, 2020, 38(6): 1183-1186.
[15] 黄碧燕 , 陈宁 .血清 Irisin及 Zonulin水平用于诊断 PCOS患者胰岛素抵抗的临床价值研究 [J].中国妇幼保健 , 2019, 34(13): 2940-2943. HUANG Biyan, CHEN Ning. Clinical value of serum Irisin and Zonulin levels in the diagnosis of insulin resistance in PCOS patients [J]. Maternal and Child Health Care of China, 2019,34(13):2940-2943.
[16] 盛清 , 邱峰龙．多囊卵巢综合征患者血清鸢尾素水平变化及临床意义 [J].中国性科学 , 2021, 30(7): 45-47.SHENG Qing, QIU Fenglong. Changes and significance of serum Irisin levels in patients with polycystic ovary syndrome [J]. Chinese Journal of Human Sexuality, 2021, 30(7): 45-47.
[17] 徐敏 , 刘礼华 , 季新梅 .血清鸢尾素联合 AMH对多囊卵巢综合征不孕症 IVF-ET治疗结局的预测作用 [J].中国性科学 , 2020, 29(6): 79-82. XU Min, LIU Lihua, JI Xinmei. Predictive effect of serum Irisin combined with AMH on the IVF-ET outcomes of infertility patients with polycystic ovary syndrome [J]. Chinese Journal of Human Sexuality,2020,29(6):79-82.
[18] WIDECKA J, OZEGOWSKA K, BANASZEWSKA B, et al. Is Copeptina new potential biomarker of insulin resistance in polycystic ovary syndrome[J]. Ginekologia Polska, 2019, 90(3): 115-121.
[19] 刘贝贝 .血清和肽素与多囊卵巢综合征患者胰岛素抵抗及动脉血管硬化的相关性研究 [J].中国医学工程 , 2020, 28(12): 13-17. LIU Beibei. Correlation of serum Copeptin and Insulin resistance and atherosclerosis of polycystic ovary syndrome patients [J]. China Medical Engineering,2020,28(12):13-17.
[20] 张先锋 , 肖丹 , 郭佳 .血清和肽素水平与 PCOS患者糖代谢相关指标水平的关系研究 [J].分子诊断与治疗杂志 , 2020, 12(7):905-909. ZHANG Xianfeng, XIAO Dan, GUO Jia. Study on relationship between serum Copeptin level and levels of glucose metabolism-related indicators in patients with PCOS [J]. Journal of Molecular Diagnostics and Therapy, 2020,12(7): 905-909.
[21] 赵智瑞 , 何国丽 , 林琳 , 等 .多囊卵巢综合征患者血清和肽素与胰岛素抵抗的相关性分析 [J].川北医学院学报 , 2021, 36(12): 1613-1616. ZHAO Zhirui, HE Guoli, LIN Lin, et al. Correlation between serum,Copeptin levels and Insulin resistance in PCOS patients [J]. Journal of North Sichuan Medical College, 2021, 36(12):1613-1616.

相似文献/References:

[1]李晓丽,赵　莉,曹阳阳,等.多囊卵巢综合征患者血清肌联素水平表达与多种生化代谢指标的相关性分析[J].现代检验医学杂志,2020,35(06):111.[doi:doi:10.3969/j.issn.1671-7414.2020.06.027]
　LI Xiao-li,ZHAO Li,CAO Yang-yang,et al.Correlation Analysis between Expression of Serum Myonectin and VariousBiochemical and Metabolic Indexes in Patients with Polycystic Ovary Syndrome[J].Journal of Modern Laboratory Medicine,2020,35(06):111.[doi:doi:10.3969/j.issn.1671-7414.2020.06.027]
[2]钟社兰,李功娟,樊阳阳,等.多囊卵巢综合征患者血清中Neudesin水平及其与多项生理生化指标的相关性分析[J].现代检验医学杂志,2021,36(02):98.[doi:doi:10.3969/j.issn.1671-7414.2021.02.023]
　ZHONG She-lan,LI Gong-juan,FAN Yang-yang,et al.Correlation Analysis of Serum Neudesin Level and Multiple Physiological and Biochemical Indexes in Patients with Polycystic Ovarian Syndrome[J].Journal of Modern Laboratory Medicine,2021,36(06):98.[doi:doi:10.3969/j.issn.1671-7414.2021.02.023]
[3]曹阳阳,樊阳阳,宋秀英,等.多囊卵巢综合征患者血清镍纹样蛋白水平检测的临床意义及与实验室指标的相关性研究[J].现代检验医学杂志,2021,36(02):111.[doi:doi:10.3969/j.issn.1671-7414.2021.02.026]
　CAO Yang-yang,FAN Yang-yang,SONG Xiu-ying,et al.Clinical Significance of Serum Metrnl Protein Level Detection in Patients with Polycystic Ovary Syndrome and Its Correlation with Laboratory Indexes[J].Journal of Modern Laboratory Medicine,2021,36(06):111.[doi:doi:10.3969/j.issn.1671-7414.2021.02.026]
[4]宋秀英,樊阳阳,赵　莉,等.多囊卵巢综合征患者血清 Spexin 水平表达及其与多项生理生化指标的相关性分析[J].现代检验医学杂志,2021,36(03):80.[doi:10.3969/j.issn.1671-7414.2021.03.018]
　SONG Xiu-ying,ZHAO Li,CAO Yang-yang,et al.Expression of Serum Spexin in Patients with Polycystic Ovary Syndrome andIts Correlation with Multiple Physiological and Biochemical Indexes[J].Journal of Modern Laboratory Medicine,2021,36(06):80.[doi:10.3969/j.issn.1671-7414.2021.03.018]
[5]林延润a,邱伟全b,彭学博,等.多囊卵巢综合征患者血清性激素水平与胰岛素释放峰值后移的相关性研究[J].现代检验医学杂志,2021,36(06):143.[doi:10.3969/j.issn.1671-7414.2021.06.031]
　LIN Yan-run,PENG Xue-bo,QIU Wei-quan,et al.Study on the Relationship between Serum Sex Hormone Level and Insulin Release Peak Shift in Patients with Polycystic Ovary Syndrome[J].Journal of Modern Laboratory Medicine,2021,36(06):143.[doi:10.3969/j.issn.1671-7414.2021.06.031]
[6]朱 琳,林延润,杨发达,等.PCOS 患者胰岛素释放试验峰值后移与胰岛素分泌总量及敏感性的特征分析[J].现代检验医学杂志,2022,37(05):154.[doi:10.3969/j.issn.1671-7414.2022.05.030]
　ZHU Lin,LIN Yan-run,YANG Fa-da,et al.Analysis of the Relationship between the Peak Shift of Insulin Release Test and Total Insulin Secretion and Sensitivity in Patients with PCOS[J].Journal of Modern Laboratory Medicine,2022,37(06):154.[doi:10.3969/j.issn.1671-7414.2022.05.030]
[7]朱 琳,陈跃瑜,林延润,等.PCOS 患者MTHFR C677T 基因多态性与胰岛素峰值后移的相关性研究[J].现代检验医学杂志,2023,38(06):54.[doi:10.3969/j.issn.1671-7414.2023.06.010]
　ZHU Lin,CHEN Yueyu,LIN Yanrun,et al.Relationship between MTHFR C677T Polymorphism and Insulin Peak Shift in Patients with PCOS[J].Journal of Modern Laboratory Medicine,2023,38(06):54.[doi:10.3969/j.issn.1671-7414.2023.06.010]
[8]古丽胡马尔·艾尼瓦尔,吐比克孜·依比力,苏比努尔·买买提,等.多囊卵巢综合征患者血清IL-36α，CTRP6水平表达与临床诊断价值研究[J].现代检验医学杂志,2024,39(06):119.[doi:10.3969/j.issn.1671-7414.2024.06.020]
　GULIHUMAER Ainiwaer,TUBIKEIZ ribili,SUBINUER Maimaiti,et al.Study on the Expression of Serum IL-36α and CTRP6 in Patients with Polycystic Ovary Syndrome and Their Clinical Diagnostic Value[J].Journal of Modern Laboratory Medicine,2024,39(06):119.[doi:10.3969/j.issn.1671-7414.2024.06.020]

备注/Memo

备注/Memo:
基金项目：湖北省卫健委联合基金面上项目(WJ2019H524)。
作者简介：鲁霞 (1979-)，女，本科，副主任医师，研究方向：妇科肿瘤，E-mail: luxia6667@163.com。
通讯作者：李晓兰(1972-)，硕士，主任医师， 研究方向：妇科肿瘤，E-mail: 27456 1305@qq.com。
更新日期/Last Update: 2022-11-15